Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AMRX

Amneal Pharmaceuticals Inc

May 07 • 10:49AM ET

13.63

+0.01 0.10 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • Mid • NASD

Peers: JNJ PFE NVS TAK TEVA PRGO FMS RDY SNN

| Held by: IJR VTI VB IWM VBR VXF SPSM XSMO IWO DFAS

Scroll to Statements

Index	RUT	P/E	36.48	EPS (ttm)	0.37	Insider Own	51.61%	Shs Outstand	319.00M	Perf Week	5.94%
Market Cap	4.35B	Forward P/E	11.37	EPS next Y	1.20	Insider Trans	-0.11%	Shs Float	154.36M	Perf Month	7.27%
Enterprise Value	6.92B	PEG	0.63	EPS next Q	0.22	Inst Own	45.27%	Short Float	5.54%	Perf Quarter	-7.69%
Income	137.86M	P/S	1.43	EPS this Y	19.71%	Inst Trans	6.03%	Short Ratio	4.55	Perf Half Y	20.13%
Sales	3.05B	P/B	-	EPS next Y	20.64%	ROA	2.01%	Short Interest	8.56M	Perf YTD	8.21%
Book/sh	-0.23	P/C	22.00	EPS next 5Y	18.16%	ROE	-	52W High	15.42 -11.58%	Perf Year	88.84%
Cash/sh	0.62	P/FCF	18.04	EPS past 3/5Y	- -18.36%	ROIC	5.31%	52W Low	7.02 94.22%	Perf 3Y	610.11%
Dividend Est.	-	EV/EBITDA	11.11	Sales past 3/5Y	10.92% 8.66%	Gross Margin	36.55%	Volatility	3.36% 3.64%	Perf 5Y	162.20%
Dividend TTM	-	EV/Sales	2.27	EPS Y/Y TTM	160.50%	Oper. Margin	13.09%	ATR (14)	0.44	Perf 10Y	-54.25%
Dividend Ex-Date	-	Quick Ratio	1.48	Sales Y/Y TTM	7.64%	Profit Margin	4.53%	RSI (14)	62.91	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	2.17	EPS Q/Q	405.32%	SMA20	4.72%	Beta	1.32	Target Price	17.00
Payout	0.00%	Debt/Eq	-	Sales Q/Q	3.97%	SMA50	6.57%	Rel Volume	0.45	Prev Close	13.62
Employees	8500	LT Debt/Eq	-	Earnings	Apr 22 BMO	SMA200	16.64%	Avg Volume	1.88M	Price	13.63
IPO	Dec 19, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	59.67% 0.40%	Trades		Volume	206,965	Change	0.10%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)